Recently diagnosed with HIV? Click here

Treating HIV

Recent advances in HIV treatments mean that people living with HIV are leading longer and more productive lives.

NAPWHA works with pharmaceutical companies, educators, clinicians and government to ensure we have access to the best treatments and information possible. NAPWHA Health & Treatments projects are also actively representing the interests of positive people in many ways.

Treataware (formerly the AIDS Treatment Project Australia) develops educational materials and organises the popular Treatments Information Roadshow and Chin Wag events all around Australia.

For detailed information about specific anti-HIV treatments, visit NAPWHA's HIV Treatments Database.

For detailed information about when to start treatment, go to When to start treatment

Beyond the barbs

Positive Living article • Jim Arachne • 19 December 2004

Peripheral neuropathy (PN) is a debilitating treatment side effectAn unwanted effect caused by the administration of drugs. Onset may be sudden or develop over time. and one of the common reasons for people stopping their anti-HIV medication. read more »

Medicare, PBS changes

Positive Living article • Paul Kidd • 19 December 2004

From January 1, changes to Medicare rebates and Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. co-payments will have some people paying less to see their GP, but will also significantly increase prescription drug costs. read more »

Undetectable

Positive Living article • Paul Kidd • 19 December 2004

Achieving undetectable viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. is the primary objective of anti-HIV therapy, but for some people it’s an unattainable goal. But now, as PAUL KIDD explains, there’s encouraging news for those who can’t quite get there. read more »

Three steps forward

Positive Living article • Paul Kidd • 19 December 2004
Treating HIV

In separate developments, scientists in Britain, the US and Germany have made discoveries about HIV which promise to significantly improve the effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. clinical trials gauge efficacy, and Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. trials confirm it. of future treatments. read more »

A tale of two cities

Positive Living article • Paul Kidd • 19 December 2004

With major medical conferences in the United States and Scotland, November was a busy month for HIV medicine. PAUL KIDD reviews some key findings. read more »

Could a spoonful of sugar make the medicine go down?

Positive Living article • Kirsty Machon • 19 December 2004

German researchers believe a nucleoside extracted from sugar cane could be the key to preventing and even reversing cell damage from HIV drugs. read more »

What's your problem?

Positive Living article • Dr Nick Medland • 19 December 2004

PL's resident medical expert, Dr Nick Medland, answers readers' letters about missing doses, starting treatments and sexually-transmitted infections. read more »

Washington lipodystrophy conference

Story • Kirsty Machon • 14 December 2004
Treating HIV

The Sixth International Workshop on Lipodystrophy and Adverse Events was held in Washington DC, USA, from 25 to 28 October 2004. NAPWHA's HIV Health Policy Officer, Kirsty Machon, attended the workshop and has filed a detailed report. read more »

Triple treat

Positive Living article • Paul Kidd • 15 October 2004

The Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. has recently added three new antiretroviralsA medication or other substance which is active against retroviruses such as HIV., to become available on prescription in December. PAUL KIDD takes a look at the newest weapons in the anti-HIV armoury. read more »

Big Mauve Door

Positive Living article • Graham Douglas-Meyer • 15 October 2004

The registrar pops out of the room. Five minutes is an eternity when you are in a hospital treatment room and don’t know what’s happening on the other side of that big mauve door. read more »

Syndicate content
Text size: font smallerfont normalfont larger

External links

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.